Chenyang Guo

735 total citations · 1 hit paper
38 papers, 502 citations indexed

About

Chenyang Guo is a scholar working on Hepatology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Chenyang Guo has authored 38 papers receiving a total of 502 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hepatology, 13 papers in Surgery and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Chenyang Guo's work include Hepatocellular Carcinoma Treatment and Prognosis (16 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers) and Cancer, Hypoxia, and Metabolism (5 papers). Chenyang Guo is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (16 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers) and Cancer, Hypoxia, and Metabolism (5 papers). Chenyang Guo collaborates with scholars based in China, South Korea and United States. Chenyang Guo's co-authors include Zheng Lin, Hai-Liang Li, Tao Qiu, Haibo Xu, Hui Zhao, Maolun Liu, Tianqi Ming, Han Yang, Shan Ren and Shun Tang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Advanced Functional Materials.

In The Last Decade

Chenyang Guo

34 papers receiving 496 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Peppermint essential oil: its phytochemistry, biological activity, pharmacological effect and application

2022 136 citations Chenyang Guo et al. profile →

Peers

Chenyang Guo

HEPAT

EPIDE

SURGE

Da‐Hee Jeong South Korea

Minyue Zhang China

Mao Mu China

Ying Ran China

Longfei Ren China

Wenyou Zhang China

Vinícius Barreto Garcia Brazil

Mimi Zhou China

Ryohei Hayashi Japan

Jun Du China

Da‐Hee Jeong South Korea

Chenyang Guo

110 ×0.6

HEPAT

145 ×1.6

105 ×1.2

EPIDE

73 ×1.0

SURGE

25 ×0.4

Citations per year, relative to Chenyang Guo Chenyang Guo (= 1×) peers Da‐Hee Jeong

Countries citing papers authored by Chenyang Guo

Since Specialization

Citations

This map shows the geographic impact of Chenyang Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chenyang Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chenyang Guo more than expected).

Fields of papers citing papers by Chenyang Guo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chenyang Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chenyang Guo. The network helps show where Chenyang Guo may publish in the future.

Co-authorship network of co-authors of Chenyang Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Chenyang Guo. A scholar is included among the top collaborators of Chenyang Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chenyang Guo. Chenyang Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Huang, Hanyao, Chenyang Guo, Jiali Chen, et al.. (2025). Controlling Alveolar Bone Loss by Hydrogel‐Based Mitigation of Oral Dysbiosis and Bacteria‐Triggered Proinflammatory Immune Response (Adv. Funct. Mater. 3/2025). Advanced Functional Materials. 35(3).

Liu, Yue, Chunli Zhang, Chenyang Guo, et al.. (2024). SlSPA3 regulates the nuclear abundance of SlUVR8 in tomato. The Plant Journal. 120(6). 2656–2667.

Zhang, Hang, et al.. (2024). Exercise training modalities in prediabetes: a systematic review and network meta-analysis. Frontiers in Endocrinology. 15. 1308959–1308959. 13 indexed citations

Sun, Madi, Tongfei Shi, Xuenian Chen, et al.. (2024). Immunogenicity-masking delivery of uricase against hyperuricemia and gout. Journal of Controlled Release. 372. 862–873. 12 indexed citations

Zhao, Qing, Hai-Liang Li, Chenyang Guo, et al.. (2024). The important role of whole-process computed tomography guidance for percutaneous gastrostomy in esophageal cancer patients who are unsuitable for or have had unsuccessful attempts with endoscopic and fluoroscopic gastrostomy. BMC Gastroenterology. 24(1). 14–14. 2 indexed citations

Sun, Madi, Peiyu Chen, Kai Xiao, et al.. (2023). Circulating Cell‐Free DNAs as a Biomarker and Therapeutic Target for Acetaminophen‐Induced Liver Injury. Advanced Science. 10(16). e2206789–e2206789. 27 indexed citations

Hu, Hongtao, et al.. (2022). Local ablation of pulmonary malignancies abutting pleura: Evaluation of midterm local efficacy and safety. Frontiers in Oncology. 12. 976777–976777. 1 indexed citations

Xu, Shi‐Jun, Yuan Guo, Hongtao Hu, et al.. (2022). Plasma arginase-1 as a predictive marker for early transarterial chemoembolization refractoriness in unresectable hepatocellular carcinoma. Frontiers in Oncology. 12. 1014653–1014653. 2 indexed citations

Guo, Yuan, Weijun Fan, Shi‐Jun Xu, et al.. (2022). Transarterial chemoembolization combined with apatinib with or without PD-1 inhibitors in BCLC stage C hepatocellular carcinoma: A multicenter retrospective study. Frontiers in Oncology. 12. 961394–961394. 15 indexed citations

10.

Li, Zhen, et al.. (2022). Prospective study of TACE combined with sorafenib vs TACE combined with 125I seed implantation in the treatment of hepatocellular carcinoma with portal vein tumor thrombus and arterioportal fistulas. Frontiers in Oncology. 12. 977462–977462. 6 indexed citations

11.

Chen, Chengshi, Ji Hoon Shin, Hailiang Li, et al.. (2021). Analysis of the factors influencing retrograde removal of double J ureteral stents using a simple snare technique in female patients. Annals of Translational Medicine. 9(8). 674–674. 2 indexed citations

12.

Hu, Hong-Tao, Junpeng Luo, Zhen Li, et al.. (2021). Hepatocellular Carcinoma With Portal Vein Tumor Thrombus Treated With Transarterial Chemoembolization and Sorafenib vs.125Iodine Implantation. Frontiers in Oncology. 11. 806907–806907. 12 indexed citations

13.

Zhao, Yuqing, Hong-Tao Hu, Yan Zhao, et al.. (2021). Gastroesophageal junction cancer with hepatic metastasis: Effective Treatment using microsphere embolization combined with transarterial infusion chemotherapy. Digestive and Liver Disease. 53(11). 1499–1505.

14.

Lin, Zheng, H. Li, Jinhua Huang, et al.. (2020). Serum midkine levels for the diagnosis and assessment of response to interventional therapy in patients with hepatocellular carcinoma. SHILAP Revista de lepidopterología. 4(1). 39–45. 6 indexed citations

15.

Hu, Hongtao, et al.. (2018). Proline-Rich Protein 11 Regulates Self-Renewal and Tumorigenicity of Gastric Cancer Stem Cells. Cellular Physiology and Biochemistry. 47(4). 1721–1728. 9 indexed citations

16.

Li, Hai-Liang, et al.. (2018). Transarterial chemoembolization with radiofrequency ablation versus hepatectomy in hepatocellular carcinoma beyond the Milan criteria: a retrospective study. Cancer Management and Research. Volume 10. 5545–5552. 9 indexed citations

17.

Jiang, Li, Dongming Han, Hongtao Hu, et al.. (2016). The value of 125iodine implantation combining transcatheter arterial chemoembolization to prevent digestive tract bleeding in patients with portal vein tumor thrombus in primary hepatocellular carcinoma. Zhonghua fangshexian yixue zazhi. 50(10). 784–788. 1 indexed citations

18.

Guo, Chenyang, et al.. (2016). Influence of lactulose on interventional therapy for HCC patients with hepatocirrhosis and hypersplenism. Asian Pacific Journal of Tropical Medicine. 9(2). 193–196. 4 indexed citations

19.

Feng, Xiaobin, Ruocai Xu, Xilin Du, et al.. (2014). Combination Therapy With Sorafenib and Radiofrequency Ablation for BCLC Stage 0–B1 Hepatocellular Carcinoma: A Multicenter Retrospective Cohort Study. The American Journal of Gastroenterology. 109(12). 1891–1899. 59 indexed citations

20.

Li, Hai-Liang, et al.. (2012). Transcatheter arterial chemoembolization combined "1"2"5iodine seed implantation for primary hepatic carcinoma with portal vein tumor thrombus thrombosis. Zhonghua fangshexian yixue zazhi. 46(6). 552–556.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact